The Compliance Case for Third-Party Manufacturing of Pharmaceuticals

Most arguments for third-party manufacturing are about money — cheaper than a plant, no capital, no idle capacity. Those are real, and they are covered here. This page is about the argument nobody makes, which is quietly the stronger one: you are also outsourcing the compliance burden, and that burden is heavier than the machinery.

What you are actually handing over

People think a plant is a building with machines in it. A licensed pharmaceutical plant is a documentation system that happens to produce tablets.

• Qualified persons on the payroll, permanently — not when you have an order.
• A QC lab with validated methods and calibrated instruments.
• Stability chambers running programmes for years, on products you may have stopped selling.
• Batch documentation for every batch ever made, retained and retrievable.
• Inspection readiness every single day, because a drug inspector does not book an appointment.
• Validation and requalification of equipment, water systems, HVAC — on a schedule that never ends.

None of that scales down when you have a slow quarter. It is a fixed obligation with a permanent headcount attached. Under a contract arrangement, it belongs to the manufacturer.

The clause that matters, in the manufacturer's own document

A WHO-GMP site certificate states it plainly: the responsibility for the quality of the individual batches of the pharmaceutical products manufactured through this process lies with the manufacturer.

That is not a courtesy. It is how the certificate is worded. The plant that made your medicine carries batch quality — legally, in the document the regulator issued them. Which is exactly why they will not skip the raw-material testing, and why the certificate of analysis is not optional.

Why a shared plant is often the more disciplined plant

This is counter-intuitive, so it is worth stating carefully.

A plant that manufactures only for its owner's brands is inspected by the drug controller and nobody else. A plant that manufactures on contract for other pharmaceutical companies is audited by every one of those customers — on their schedule, to their standard, with their brand going on the strip and their reputation riding on it, and with the power to cancel a contract.

That happens whether the plant enjoys it or not. It is a harder inspection regime than most brand owners could ever impose alone. So "we outsource" and "our quality is weaker" are not the same sentence — often the opposite.

Which makes the useful question: who else does this plant manufacture for? You will never audit a plant yourself. You only need to know who already does.

The compliance limit you must check

Outsourcing compliance does not mean outsourcing your due diligence, and there is one place it bites.

A site certificate lists the exact dosage forms a plant may produce. A site certified for tablets, capsules, external preparations and oral liquids cannot legally make your injectable or your eye drop. Beta-lactam antibiotics need physically segregated premises — that is regulation. Ophthalmics and injectables need sterile lines.

So ask for the certificate and read the dosage-form table on it. Not the claim — the table. That is the single check that separates a compliant arrangement from an expensive problem.

What stays yours

Trademark clearance, demand forecasting, unsold stock, and your market. The manufacturer makes what you order to the agreed specification. It does not check that your brand name is available, and it does not carry your inventory risk. Here is the full split of who is responsible for what.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024, based on inspections on 30 September, 1 October and 21 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids, for production, packing and quality control. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them.

Who else audits it: the plant manufactures on contract for other Indian pharmaceutical companies, whose auditors go through the batch records with the power to cancel.

Not building your own brand? A PCD pharma franchise carries none of this — you sell an existing certified range in a monopoly territory, from ₹25,000. Here is the difference.

Frequently asked questions

What are the quality benefits of third-party manufacturing?

You outsource a permanent compliance burden: qualified persons, a QC lab, stability chambers, batch documentation and daily inspection readiness. A WHO-GMP site certificate states that responsibility for individual batch quality lies with the manufacturer, so the obligation is legally theirs, not a promise in your contract.

Is outsourced manufacturing lower quality than in-house?

Not necessarily, and often the reverse. A plant making stock only for its owner is inspected by the drug controller alone. A plant manufacturing on contract for other pharmaceutical companies is audited by all of them, on their schedule, with the power to cancel. That is a harder regime than most brand owners could impose alone.

Who is legally responsible for pharmaceutical batch quality?

The manufacturer. The WHO-GMP site certificate states responsibility for the quality of individual batches lies with the manufacturer. Batch manufacturing records and certificates of analysis are the evidence, and they should arrive with every consignment as standard rather than on request.

What compliance check must I do myself?

Read the dosage-form table on the manufacturer's site certificate. A plant certified for tablets, capsules, external preparations and oral liquids cannot legally make your injectable or ophthalmic. Beta-lactams need segregated premises; sterile forms need sterile lines. Check the table, not the certification claim.